FindTrial
Sign In

Retrospective study for integrate Chinese and conventional medicine treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province

Retrospective studyfor integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030492
Enrollment
Unknown
Registered
2020-03-04
Start date
2020-03-04
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Control group:Western medicine treatment
Experimental group:integrate Chinese and conventional medicine treatment

Sponsors

The First Affiliated Hospital of Hu'nan University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The diagnostic criteria of novel coronavirus infection pneumonia can be observed and agreed by the patients themselves.

Exclusion criteria

Exclusion criteria: pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
TCM syndrome;—

Countries

China

Contacts

Public ContactCHEN Xinyu

The First Affiliated Hospital of Hu'nan University of traditional Chinese Medicine

chenxinyuchen@163.com+86 13807312410

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026